Author

Julius Teahton

Observed name: Teahton, Julius

Institution: National Public Health Institute of Liberia

Observed institution: National Public Health Institute of Liberia

ORCID: 0000-0002-9052-3993

Observed ORCID: 0000-0002-9052-3993

OpenAlex ID: A5056349713

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

2024 · Aurélie Wiedemann, Edouard Lhomme, et al. · Nature Communications · 25

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

2023 · Andrew W Lee, Ken Liu, et al. · Clinical Infectious Diseases · 19

Epidemiological characteristics of Lassa fever cases in Liberia: a retrospective analysis of surveillance data, 2019–2020

2022 · Ralph Weah Jetoh, Shruti Malik, et al. · International Journal of Infectious Diseases · 18

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

2024 · Simon Valayer, Marie Alexandre, et al. · Emerging Microbes & Infections · 6

Baseline Seroprevalence of Arboviruses in Liberia Using a Multiplex IgG Immunoassay

2025 · Albert To, Varney M. Kamara, et al. · Tropical Medicine and Infectious Disease · 4

A Serological Multiplexed Immunoassay (MIA) Detects Antibody Reactivity to SARS-CoV-2 and Other Viral Pathogens in Liberia and Is Configurable as a Multiplexed Inhibition Test (MINT)

2024 · Brien K. Haun, Albert To, et al. · Immuno · 4

Works count: 8

Citation count: 76

H-index: 4

I10-index: 3